{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:35:37Z","timestamp":1790847337701,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370978"],"award-info":[{"award-number":["81370978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00375","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:35:58Z","timestamp":1560299758000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Expanding the Clinical Spectrum of Osteogenesis Imperfecta Type V: 13 Additional Patients and Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Yang-Jia","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V osteogenesis imperfecta: a new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"J Bone Miner Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","article-title":"A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V","volume":"91","author":"Cho","year":"2012","journal-title":"Am J Hum Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","article-title":"A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus","volume":"91","author":"Semler","year":"2012","journal-title":"Am J Hum Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1359\/jbmr.080412","article-title":"Bril: a novel bone-specific modulator of mineralization","volume":"23","author":"Moffatt","year":"2008","journal-title":"J Bone Miner Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"E325","DOI":"10.1210\/jc.2014-3082","article-title":"Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression","volume":"100","author":"Reich","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/jbmr.1891","article-title":"Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation","volume":"28","author":"Shapiro","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/MCD.0b013e32836032f0","article-title":"Genotype-phenotype study in type V osteogenesis imperfecta","volume":"22","author":"Balasubramanian","year":"2013","journal-title":"Clin Dysmorphol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/aps.2010.91","article-title":"Polymorphisms in the HOXD4 gene are not associated with peak bone mineral density in Chinese nuclear families","volume":"31","author":"Zhang","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ajcn\/68.5.1111","article-title":"Total-body and regional bone mineral content and areal bone mineral density in children aged 8\u201318 y: the Fels Longitudinal Study","volume":"68","author":"Maynard","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00198-013-2418-2","article-title":"Reference values of bone mineral density and prevalence of osteoporosis in Chinese adults","volume":"25","author":"Zhang","year":"2014","journal-title":"Osteoporos Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e82098","DOI":"10.1371\/journal.pone.0082098","article-title":"Bone mineral density of the spine in 11,898 chinese infants and young children: A Cross-Sectional Study","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bone.2010.12.013","article-title":"Normative data and percentile curves for Dual Energy X-ray Absorptiometry in healthy Indian girls and boys aged 5-17 years","volume":"48","author":"Khadilkar","year":"2011","journal-title":"Bone"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e47264","DOI":"10.1371\/journal.pone.0047264","article-title":"High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E665","DOI":"10.1210\/jc.2013-2086","article-title":"Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women","volume":"99","author":"He","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0190264","DOI":"10.1371\/journal.pone.0190264","article-title":"Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing","volume":"13","author":"Patch","year":"2018"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix049","article-title":"Comparative performance of the BGISEQ-500 vs Illumina HiSeq2500 sequencing platforms for palaeogenomic sequencing","volume":"6","author":"Mak","year":"2017","journal-title":"Gigascience."},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jmedgenet-2012-101307","article-title":"Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.\u221214C> T mutation in all patients","volume":"50","author":"Rauch","year":"2013","journal-title":"J Med Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cca.2016.09.019","article-title":"Osteogenesis imperfecta type V: genetic and clinical findings in eleven Chinese patients","volume":"462","author":"Liu","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/jbmr.1983","article-title":"Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene","volume":"28","author":"Grover","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e72337","DOI":"10.1371\/journal.pone.0072337","article-title":"Phenotype and genotype analysis of chinese patients with osteogenesis imperfecta type V","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/ajmg.a.36024","article-title":"Osteogenesis imperfecta type V: clinical and radiographic manifestations in mutation confirmed patients","author":"Kim","year":"2013","journal-title":"Am J Med Genet A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/ajmg.a.36025","article-title":"A recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V","author":"Takagi","year":"2013","journal-title":"Am J Med Genet A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ajmg.a.36409","article-title":"Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta","author":"Guillen-Navarro","year":"2014","journal-title":"Am J Med Genet A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2474-15-107","article-title":"The IFITM5 mutation c.\u221214C> T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V","volume":"15","author":"Lazarus","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000439506","article-title":"Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V","volume":"6","author":"Brizola","year":"2015","journal-title":"Mol Syndromol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.2106\/JBJS.F.01287","article-title":"Radial head dislocation and subluxation in osteogenesis imperfecta","volume":"89","author":"Fassier AM","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"B27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2106\/JBJS.L.01596","article-title":"Behavior of scoliosis during growth in children with osteogenesis imperfecta","volume":"96","author":"Anissipour","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"B28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bone.2016.02.018","article-title":"Scoliosis in osteogenesis imperfecta caused by COL1A1\/COL1A2 mutations\u2014genotype-phenotype correlations and effect of bisphosphonate treatment","volume":"86","author":"Sato","year":"2016","journal-title":"Bone."},{"key":"B29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bone.2017.11.013","article-title":"Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice","volume":"107","author":"Rauch","year":"2018","journal-title":"Bone."},{"key":"B30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/jbmr.2363","article-title":"A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation","volume":"30","author":"Lietman","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/mgg3.257","article-title":"Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta","volume":"5","author":"Caparros-Martin","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/BF01955060","article-title":"Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome)","volume":"152","author":"Brenner","year":"1993","journal-title":"Eur J Pediatr."},{"key":"B33","first-page":"83","article-title":"A remarkable case of diffuse cancellous osteoma of the femur, following a fracture, in which similar growths afterwards developed in connection with other bones","volume":"1","author":"Battle","year":"1908","journal-title":"Proc R Soc Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00774-015-0667-1","article-title":"IFITM5 mutations and osteogenesis imperfecta","volume":"34","author":"Hanagata","year":"2016","journal-title":"J Bone Miner Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0022-3476(82)80153-4","article-title":"Prostaglandin synthetase inhibitor in Caffey disease","volume":"101","author":"Heyman","year":"1982","journal-title":"J Pediatr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1172\/JCI22760","article-title":"A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders","volume":"115","author":"Gensure","year":"2005","journal-title":"J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.joms.2007.09.007","article-title":"Infantile cortical hyperostosis (Caffey Disease): a review","volume":"66","author":"Kamoun-Goldrat","year":"2008","journal-title":"J Oral Maxillofac Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3109\/17453677508989258","article-title":"Infantile cortical hyperostosis. Follow-up of 29 cases","volume":"46","author":"Finsterbush","year":"1975","journal-title":"Acta Orthop Scand"},{"key":"B39","first-page":"80","article-title":"Hitherto undescribed characteristics of the pathology of infantile cortical hyperostosis (Caffey's disease)","volume":"101","author":"Eversole","year":"1957","journal-title":"Bull Johns Hopkins Hosp"},{"key":"B40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbrc.2011.04.136","article-title":"Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferoninduced genes","volume":"409","author":"Hanagata","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e75831","DOI":"10.1371\/journal.pone.0075831","article-title":"Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells","volume":"8","author":"Tsukamoto","year":"2013","journal-title":"PLoS ONE"},{"key":"B42","doi-asserted-by":"publisher","first-page":"650","DOI":"10.24953\/turkjped.2016.06.011","article-title":"Familial mutation in Caffey disease with reduced penetrance: a case report","volume":"58","author":"\u00d6zdemir","year":"2016","journal-title":"Turk J Pediatr"},{"key":"B43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00003086-199602000-00043","article-title":"A case of recurrent Caffey's disease treated with naproxen","author":"Thometz","year":"1996","journal-title":"Clin Orthop Relat Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1440-1754.2001.00633.x","article-title":"Indomethacin treatment of infantile cortical periostosis in twins","volume":"37","author":"Couper","year":"2001","journal-title":"J Paediatr Child Health"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:36:00Z","timestamp":1560299760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":44,"alternative-id":["10.3389\/fendo.2019.00375"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00375","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,12]]},"article-number":"375"}}